LSE - Delayed Quote GBp
Bioventix PLC (BVXP.L)
At close: 3:49 PM GMT
Breakdown
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Assets
13,281.71
13,117.59
12,907.17
13,299.80
Total Liabilities Net Minority Interest
1,217.94
1,296.44
1,086.86
778.87
Total Equity Gross Minority Interest
12,063.77
11,821.15
11,820.31
12,520.93
Total Capitalization
12,063.77
11,821.15
11,820.31
12,520.93
Common Stock Equity
12,063.77
11,821.15
11,820.31
12,520.93
Net Tangible Assets
12,063.77
11,821.15
11,820.31
12,520.93
Working Capital
10,896.23
10,561.02
10,444.64
11,242.63
Invested Capital
12,063.77
11,821.15
11,820.31
12,520.93
Tangible Book Value
12,063.77
11,821.15
11,820.31
12,520.93
Share Issued
5,219.66
5,209.33
5,209.33
5,207.84
Ordinary Shares Number
5,219.66
5,209.33
5,209.33
5,207.84
6/30/2020 - 4/29/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
22UA.DU BioNTech SE
99.10
-0.75%
SBTX.L SkinBioTherapeutics plc
14.25
-3.39%
IBT.L International Biotechnology Ord
710.00
+1.14%
FUM.L Futura Medical plc
38.40
0.00%
OXB.L Oxford Biomedica plc
417.00
+0.36%
AVCT.L Avacta Group Plc
50.00
+3.20%
PGEN Precigen, Inc.
0.9891
+10.49%
ZEAL.CO Zealand Pharma A/S
813.50
-5.08%
BAVA.CO Bavarian Nordic A/S
204.00
+2.00%
CPRX Catalyst Pharmaceuticals, Inc.
23.53
+3.61%